ScottR., GregoryR., HinesN., CarrollC., HymanN., PapanasstasiouV., LeatherC., RoweJ., SilburnP., & AzizT. (1998). Neuropsychological, neurological and functional outcome following pallidotomy for Parkinson's disease. A consecutive series of eight simultaneous bilateral and twelve unilateral procedures. Brain121, 659–675.
3.
CombesR.D. (2006). Alternatives to animal testing. In: TriggleD., & TaylorJ. (eds.), Comprehensive Medicinal Chemistry II, Oxford, UK: Elsevier Ltd. (in press).
BhogalN., GrindonC., CombesR., & BallsM. (2005). Toxicity testing: creating a revolution based on new technologies. Trends in Biotechnology23, 299–307.
SoulsbyL., & MortonD. (eds.) (2001). Pain: Its Nature and Management in Man and Animals124 pp. London, UK: Royal Society of Medicine Press.
8.
Anon. (2005). The Ethics of Research involving Animals, 376 pp. London, UK: Nuffield Council of Bioethics. Website www.nuffield-bioethics.org. (Accessed 25.09.06).
9.
WestmorelandC. (2006). Alternative tests and the 7th Amendment to the Cosmetics Directive. In Issues in Environmental Science and Technology, Vol 23: Alternatives to Animal Testing, (HesterR.E., & HarrisonR.M. eds.), pp. 95–118. Cambridge, UK: Royal Society of Chemistry Publishing.
10.
BallsM., GoldbergA.M., FentemJ.H., BroadheadC.L., BurchR.L., FestingM.F.W., FrazierJ.M., HendriksenC.F.M., JenningsM., van der KampM.D.O., MortonD.B., RowanA.N., RussellC., RussellW.M.S., SpielmannH., StephensM.L., StokesW.S., StraughanD.W., YagerJ.D., ZurloJ., & van ZutphenB.F.M. (1995). The Three Rs: The way forward. The report and recommendations of ECVAM workshop 11. ATLA23, 838–866.
11.
BhogalN., & CombesR. (2006). TGN1412: time to change the paradigm for the testing of new pharmaceuticals. ATLA34, 225–239.
12.
BallsM. (2006). Primates in medical research: the plot thickens. ATLA34, 271–272.